英語論文 - St. Marianna University School of Medicine · Effect of cosyntropin during adrenal...

聖マリアンナ医科大学代謝・内分泌内科

英語論文 ■2020年 Ohno Y, Sone M, Inagaki N, Kawashima A, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Ichijo T,

Katabami T, Wada N, Sakamoto R, Ogawa Y, Yoshimoto T, Yamada T, Kawashima J, Matsuda Y, Kobayashi

H, Kamemura K, Yamamoto K, Otsuki M, Okamura S, Izawa S, Okamoto R, Tamura K, Tanabe A, Naruse M;

JPAS/JRAS Study Group

Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy

in Primary Aldosteronism

Hypertension 75:1475-1482, 2020

Naruse M, Yamamoto K, Katabami T, Nakamaru R, Sone M, Kobayashi H, Tanabe A

Age, Gender, and Body Mass Index as Determinants of Surgical Outcome in Primary Aldosteronism

Horm Metab Res 52:454-458, 2020

Tsujimoto H, Kasahara T, Sueta SI, Araoka T, Sakamoto S, Okada C, Mae SI, Nakajima T, Okamoto N,

Taura D, Nasu M, Shimizu T, Ryosaka M, Li Z, Sone M, Ikeya M, Watanabe A, Osafune K.

A Modular Differentiation System Maps Multiple Human Kidney Lineages from Pluripotent Stem

Cells

Cell Rep 31:107476, 2020

Saiki A, Otsuki M, Tamada D, Kitamura T, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M,

Wada N, Yanase T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K,

Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M

Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary

Aldosteronism

J Clin Endocrinol Metab 105:dgaa177, 2020

Taura D, Nakao K, Nakagawa Y, Kinoshita H, Sone M, Nakao K MD

C-type natriuretic peptide (CNP)/Guanylate cyclase B (GC-B) system and endothelin-1(ET-1)/ET

receptor A and B system in human vasculature

Can J Physiol Pharmacol 2020, in press

Nakamaru R, Yamamoto K, Rakugi H, Akasaka H, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada

N, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Okamoto R, Fujita M, Kobayashi H, Tamura K, Kamemura

K, Okamura S, Kakutani M, Tanabe A, Naruse M; JPAS/JRAS Study Group

Obesity predicts persistence of resistant hypertension after surgery in patients with primary

aldosteronism

Clin Endocrinol (Oxf) 2020, in oress

Hatoko T, Murakami T, Sone M, Yabe D, Masui T, Nakamoto Y, Furuta A, Uza N, Kodama Y, Harada N,

Ogura M, Yasoda A, Inagaki N

Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center

Experience of Five Consecutive Cases

Intern Med 2020, in press

Saiki Aya, Otsuki Michio, Mukai Kosuke, Hayashi Reiko, Shimomura Iichiro, Kurihara Isao, Ichijo Takamasa,

Takeda Yoshiyu, Katabami Takuyuki, Tsuiki Mika, Wada Norio, Ogawa Yoshihiro, Kawashima Junji, Sone

Masakatsu, Inagaki Nobuya, Yoshimoto Takanobu, Okamoto Ryuji, Takahashi Katsutoshi, Kobayashi Hiroki,

Tamura Kouichi, Kamemura Kohei, Yamamoto Koichi, Izawa Shoichiro, Kakutani Miki, Yamada Masanobu,

Tanabe Akiyo, Naruse Mitsuhide, JPAS/JRAS Study Group

Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism

J Endocr Soc 4:1-12, 2020

Hiroki Kobayashi, Yoshihiro Nakamura, Masanori Abe, Isao Kurihara, Hiroshi Itoh, Takamasa Ichijo, Yoshiyu

Takeda, Takashi Yoneda, Takuyuki Katabami, Mika Tsuiki, Norio Wada, Yoshihiro Ogawa, Ryuichi Sakamoto,

Junji Kawashima, Masakatsu Sone, Nobuya Inagaki, Takanobu Yoshimoto, Tetsuya Yamada, Ryuji Okamoto,

Yuichi Matsuda, Megumi Fujita, Minemori Watanabe, Kouichi Tamura, Akiyo Tanabe, Mitsuhide Naruse,


Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism:

analysis of surgical outcome

Eur J Endocrinol 182:265-273, 2020

Ishii S, Nagai Y, Kato H, Fukuda H, Tanaka Y

Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in

Patients With Type 2 Diabetes

J Clin Med Res 12:122-126, 2020

■2019年 Nakagawa T, Nagai Y, Yamamoto Y, Miyachi A, Hamajima H, Mieno E, Takahashi M, Inoue E, Tanaka Y

Effects of anagliptin on plasma glucagon levels and gastric emptying in patients with type 2

diabetes: an exploratory randomized controlled trial versus metformin

Diabetes Res Clin Pract 158:107892, 2019

Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y,

Sone M, Tsuiki M, Shibata H, Kawashima J, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Suzuki T,

JPAS Study Group

Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide

Cohort

J Endocr Soc 3:2012-2022, 2019

Kyo C, Usui T, Kosugi R, Torii M, Yonemoto T, Ogawa T, Kotani M, Tamura N, Yamamoto Y, Katabami T,

Kurihara I, Saito K, Kanamoto N, Fukuoka H, Wada N, Murabe H, Inoue T

ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of

Variant Carriers

J Endocr Soc 3:1837-1846, 2019

Takekoshi K, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura , Tanaka T, Matsuda

T, Imai T, Yamada M, Asada S, Kawata N, Naruse M

Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for

evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II

study

Endocr J 66:1063-1072, 2019

Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y,

Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H,

Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T,

Umakoshi H, Ogasawara T, Tsuiki M, Naruse M, JPAS Study Group

Historical changes and between-facility differences in adrenal venous sampling for primary

aldosteronism in Japan

J Hum Hypertens 34:34-42, 2020

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi , Ichijo , Katabami T, Wada N,

Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y,

Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M

Renal impairment is closely associated with plasma aldosterone concentration in patients with

primary aldosteronism

Eur J Endocrinol 181:339-350, 2019

Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y,

Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M,


Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in

Nonlateralized Hyperaldosteronism

J Clin Endocrinol Metab 104:4382-4389, 2019

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M,

Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M,

Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M, JPAS/JRAS Study Group

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary

Aldosteronism and Long-Term Decline in Renal Function

Hypertension 74:630-638, 2019

Akasaka H, Yamamoto K, Rakugi H, Nagasawa M, Nakamaru R, Ichijo T, Takeda Y, Kurihara I, Katabami T,

Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Kamemura K, Yoshimoto T, Matsuda Y, Fujita M,

Kobayashi H, Watanabe M, Tamura K, Okamura S, Miyauchi S, Izawa S, Chiba Y, Tanabe A, Naruse M,

Japan Primary Aldosteronism Study Group

Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients

With Primary Aldosteronism


Wada N, Shibayama Y, Yoneda T, Katabami T, Kurihara I, Tsuiki M, Ichijo T, Ogawa Y, Kawashima J, Sone M,

Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Tamura K, Kamemura K, Otsuki M, Okamura S, Naruse M,


Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary

Aldosteronism

J Endocr Soc 3:1393-1402, 2019

Nagai Y, Fukuda H, Kawanabe S, Nakagawa T, Ohta A, Tanaka Y

Differing Effect of the Sodium-Glucose Contransporter 2 Inhibitor Ipragliflozin on the Decrease of

Fat Mass vs. Learn Mass in Patients With or Without Metformin Therapy

J Clin Med Res 11:297-300, 2019

Nakamura Y, Nagai Y, Toshio K, Furukawa K, Oikawa Y, Shimada A, Tanaka Y

Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of

Terminal Restriction Fragment Length Polymorphisms

J Clin Med Res 11:401-406, 2019

Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Kurihara I, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y,

Kawashima J, Sone M, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K,

Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group.

Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of

primary aldosteronism

J Hypertens 37:1077-1082, 2019

Ishii S, Nagai Y, Sada Y, Fukuda H, Nakamura Y, Matsuba R, Nakagawa T, Kato H, Tanaka Y

Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese

Patients With Type 2 Diabetes: A Prospective Case Series

J Clin Med Res 11:219-224, 2019

Kawanabe S, Nagai Y, Nakamura Y, Nishine A, Nakagawa T, Tanaka Y

Association of the muscle/fat mass ratio with insulin resistance in gestational diabetes mellitus

Endocr J 66:75-80, 2019

Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N,

Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M,

Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki

T, and Naruse M, JPAS/JRAS Study Group

Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with

unilateral primary aldosteronism

J Hypertens 37:1513-1520, 2019

Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T,

Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N,

Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y,

Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y,

Kai T, Suzuki T, Kawamura T,and Naruse M, Japan Primary Aldosteronism Study Group

High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With

Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A

Large, Multicenter Cohort Study in Japan

Diabetes Care 42:938-945, 2019

Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I,

Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki

N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y,

Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, and Naruse M, JPAS Study Group

Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal

venous sampling

J Hypertens 37:1493-1499, 2019

Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G,

Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H,

Tanaka K, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y,

Mokubo A, Motomiya T, Waseda M, Miyakawa M, Terauchi Y, Tanaka Y, Matsuba I

Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified

Comparison at One Year in the ASSIST-K Study

J Clin Med Res 11:311-320, 2019

■2018年 Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Katabami T, Ichijo T,

Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y,

Shibata H, Kamemura K, Yanase T, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Nanba K, Tanabe A, Suzuki T,

Naruse M; JPAS Study Group.

Development and validation of subtype prediction scores for the workup of primary aldosteronism.

J Hypertens 36:2269-2276, 2018

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T,

Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi

S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group.

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism


Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki

M, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N,

Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y,

Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T; JPAS Study Group.

Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly


Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T,

Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M0, Inagaki N0, Takahashi K,

Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A,

Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T,

Suzuki T, Kawamura T, Naruse M.

Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in

Primary Aldosteronism

J Endocr Soc 2:893-902, 2018

Nagai Y, Nishine A, Hashimoto E, Nakayama T, Sasaki Y, Murakami M, Ishii S, Kato H, Tanaka Y

Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in

Japanese patients with inadequately controlled type 2 diabetese: A 4-week, randomized, open-label,

treat-to-target study

J Diabetes Investig 9:567-572, 2018

Murakami M, Nagai Y, Tenjin A, Tanaka Y

Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a

case-control study

Endocr J 65:639-643, 2018

Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T,

Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K,

Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T

The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for


J Endocr Soc 2:398-407, 2018

Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo

T

New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan

Endocrine Society

Endocr J 65:383-393, 2018

Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y,

Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, obayashi

H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S,

Suzuki T, Tsuiki M, Naruse M; JPAS Study Group

Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients

with hypokalaemia and elevation of aldosterone in primary aldosteronism

Clin Endocrinol (Oxf). 88:645-651, 2018

Matsuba R, Matsuba I, Shimokawa M, Nagai Y, Tanaka Y

Tofogliflozin decreases body fat mass and improves peripheral insulin resistance

Diabetes Obes Metab 20:1311-1315, 2018

Matsuba I, Matsuba R, Ishibashi S, Yamashita S, Arai H, Yokote K, Suganami H, Araki E

Effects of a novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate, on

hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance

J Diabetes Investig 9:1323-1332, 2018

Ikuno M, Yamada T, Shinjo Y, Morimoto T, Kumano R, Yagihashi K, Katabami T, Nakajima Y

Selective venous sampling supports localization of adenoma in primary hyperparathyroidism

Acta Radiol Open 7:1-9, 2018

Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda

T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K

Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in

Japan

Endocr J 65:359-371, 2018

Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y,

Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H,

Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M, JPAS Study Group

Significance of Computed Tomograpy and Serum Potassium in Predicting Subtype Diagnosis of



Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M,

Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K,

Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K,

Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T,

Kawamura T, Tabara Y, Naruse M; Nagahama Study; JPAS Study Group.

Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter

Study in Japan


■2017年 Sasaki Y, Katabami T, Asai S, Fukuda H, Tanaka Y

In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for

diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels

determined using liquid chromatography-tandem mass spectrometry

Endocr J 64:833-842, 2017

Ohta A, Kato H, Ishii S, Sasaki Y, Nakamura Y, Nakagawa T, Nagai Y, Tanaka Y

Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and

abdominal visceral fat volume in patients with type 2 diabetes

Expert Opin Pharmacother 18:1433-1438, 2017

Iemitsu K, Kawata T, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A,

Takeda H, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K,

Asakura T, Kubota A, Aoyanagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H,

Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2

Diabetes Duration: Interim Report of the ASSIGN-K Study

J Clin Med Res 9:793-801, 2017

Yamada T, Ikuno M, Shinjo Y, Hiroishi A, Matsushita S, Morimoto T, Kumano R, Yagihashi K, Katabami T

Selective venous sampling for primary hyperparathyroidism: how to perform an examination and

interpret the results with reference to thyroid vein anatomy

Jpn J Radiol 35:409-416, 2017

Kawata T, Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A,

Takeda H, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K,

Asakura T, Kubota A, Aoyanagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H,


Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes

Mellitus

J Clin Med Res 9:586-595, 2017

Ohta A, Kato H, Ishii S, Nagai Y, Tanaka Y

Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of

Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia

J Clin Med Res 9:476-481, 2017

Nakayama T, Nagai Y, Uehara Y, Nakamura Y, Ishii S, Kato H, Tanaka Y

Eating glutinous brown rice twice a day for 8 weeks improves glycemic control in Japanese patients

with diabetes mellitus

Nutr Diabetes 7:e273, 2017

Terashima Y, Nagai Y, Kato H, Ohta A, Tanaka Y

Eating glutinous brown rice for one day improves glycemic control in Japanese patients with type 2

diabetes assessed by continuous glucose monitoring Asia Pac J Clin Nutr 26:421-426, 2017

Asai S, Katabami T, Tsuiki M, Tanaka Y, Naruse M

Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment

Improves Survival in Patients with Metastatic and Unresectable Malignant

Pheochromocytomas/Paragangliomas

Horm Cancer 8:108-118, 2017

Nagai Y, Ohta A, Sada Y, Kato H, Tanaka Y

Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with

type 2 diabetes

Expert Opin Pharmacother 18:13-17, 2017

■2016年 Yanase T, Tajima T, Katabami T, Iwasaki Y, Tanahashi Y, Sugawara A, Hasegawa T, Mune T, Oki Y,

Nakagawa Y, Miyamura N, Shimizu C, Otsuki M, Nomura M, Akehi Y, Tanabe M, Kasayama S

Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a japan Endocrine Society

clinical practice guideline[Opinion]

Endocr J 63:765-784, 2016

Uzu T, Araki S, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T, Nishimura

M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M,

Nishiyama A, Kobori H, Maegawa H, The Shiga Committee for Preventing Diabetic Nephropathy

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in

Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial

PLOS ONE 11: e0164936, 2016

Nemoto K, Ugi S, Ogaku S, Nakaizumi N, Kato T, Fuse K, Sekine O, Morino K, Tanaka T, Maegawa H

A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in

a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion

Diabetol Int 7: 447-450, 2016

Katabami T, Ishii S, Obi R, Asai S, Tanaka Y

Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing

subclinical cortisol overproduction from unilateral adenomas

Endocr J 63:1123-1132, 2016

Nagai Y, Murakami M, Igarashi K, Nakamura Y, Tsukiyama H, Matsubara F, Nishine A, Ohshige T, Ishii S,

Kato H, Tanaka Y

Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes

assessed by continuous glucose monitoring

Endocr J 63:1099-1106, 2016

Matsubara F, Nagai Y, Tsukiyama H, Shimizu H, Yamanouchi E, Iwamoto T, Sada Y, Kato H, Ohta A, Tanaka

Y

Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed

by proton magnetic resonance spectroscopy in a Japanese population

Diabetes Res Clin Pract 119: 75-82, 2016

Tsukiyama H, Nagai Y, Matsubara F, Shimizu H, Iwamoto T, Yamanouchi E, Sada Y, Kato H, Ohta A, Tanaka

Y

Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat

volume in a Japanese population

J Diabetes Investig 7: 587-593, 2016

Iemitsu K, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H,

Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K,

Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Obana M, Sasai N, Kaneshige H, Miyakawa M,

Tanaka Y, Terauchi Y, Matsuba I Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2

Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

J Clin Med Res 8: 373-378, 2016 Yuasa S, Sato K, Takai M, Ishikawa M, Umezawa S, Kubota A, Maeda H, Kanamori A, Miyakawa M, Tanaka

Y, Terauchi Y, Matsuba I

Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients

With Type 2 Diabetes

J Clin Med Res 8: 461-471, 2016

Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H,

Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K,

Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H,


Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of

the ASSIGN-K Study

J Clin Med Res 8: 116-125, 2016

Imamura M, Takahashi A, Yamauchi T, Hara K, Yasuda K, Grarup N, Zhao W, Wang X, Huerta-Chagoya A,

Hu C, Moon S, Long J, Kwak SH, Rasheed A, Saxena R, Ma RC, Okada Y, Iwata M, Hosoe J, Shojima N,

Iwasaki M, Fujita H, Suzuki K, Danesh J, Jørgensen T, Jørgensen ME, Witte DR, Brandslund I, Christensen

C, Hansen T, Mercader JM, Flannick J, Moreno-Macías H, Burtt NP, Zhang R, Kim YJ, Zheng W, Singh JR,

Tam CH, Hirose H, Maegawa H, Ito C, Kaku K, Watada H, Tanaka Y, Tobe K, Kawamori R, Kubo M, Cho YS,

Chan JC, Sanghera D, Frossard P, Park KS, Shu XO, Kim BJ, Florez JC, Tusié-Luna T, Jia W, Tai ES,

Pedersen O, Saleheen D, Maeda S, Kadowaki T

Genome-wide association studies in the Japanese population identify seven novel loci for type 2

diabetes

Nat Commun 2016, in press

Matsuba R, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A,

Kawamori R, Maeda S

Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally

Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies

PLOS ONE 11: e0154093, 2016

Tenjin A, Nagai Y, Yuji S, Ishii S, Kato H, Ohta A, Tanaka Y

Short-term change of carotid intima-media thickness after treatment of hyperglycemia in patients

with diabetes: a cross -sectional study

BMC Res Notes 9: 281, 2016

Matsubara F, Katabami T, Asai S, Ariizumi Y, Maeda I, Takagi M, M McNamara K, Ono K, Maekawa T,

Nakamura Y, Tanaka Y, Sasano H

Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic

schwannoma/peripheral nerve sheath tumour

J Int Med Res 44: 662-672, 2016

■2015年 Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, Study Group of Diabetes Committee,

Kanagawa Physicians Association

Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes

Diabetes Res Clin Pract 108: e42-45, 2015

Nakamura Y, Nagai Y, Terashima Y, Nishine A, Ishii S, Kato H, Ohta A, Tanaka Y

Better response to the SGLT2 inhibitor dapagliflozin in young adults with type 2 diabetes

Expert Opin Pharmacother 16: 2553-2559, 2015

Matsuba R, Sakai K, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K,

Kashiwagi A, Kawamori R, Maeda S

Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci,

Identified in European Genome-Wide Association Studies, and Type 2 Diabetes

PLOS ONE 10: e0126363, 2015

Kato H, Nagai Y, Ohta A, Tenjin A, Nakamura Y, Tsukiyama H, Sasaki Y, Fukuda H, Ohshige T, Terashima Y,

Sada Y, Kondo A, Sasaoka T, Tanaka Y

Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes


Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y,

Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M

Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype

evaluation of primary aldosteronism.

Clin Endocrinol (Oxf) 83: 462-467, 2015

■2014年 Kawata T, Kanamori A, Kubota A, Maeda H, Amamiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K,

Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y,

Terauchi Y, Toyoda M, Suzuki D, Tanaka Y, Matsuba I

Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients

Diabetol Int 5: 98-104, 2014

Asai S, Ohta A, Kato H, Sada Y, Nagai Y, Kondo A, Sasaoka T, Tanaka Y

Effect of sitagliptin on glycemic control and beta cell function in Japanese patients given

basal-supported oral therapy for type 2 diabetes

Endocr J 61: 1213-1220, 2014

Tanase-Nakao K, Naruse M, Nanba K, Tsuiki M, Tagami T, Usui T, Okuno H, Shimatsu A, Hashimoto S,

Katabami T, Ogo A, Okumura A, Umakoshi H, Suzuki T

Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients

with primary aldosteronism

Clin Endocrinol (Oxf) 81: 665-670, 2014

Kawashima ST, Usui T, Tenjin A, Asai S, Tanaka Y, Hoshikawa M, Shimatsu A, Katabami T

A In Silico Analysis Identification of a Novel Germ-Line VHL Mutation in a Patient of Malignant

Pheochromocytoma

Endocr Pract 20: e96-e101, 2014

Katabami T, Murakami M, Kobayashi S, Matsui T, Ujihara M, Takagi S, Higa M, Ichijo T, Ohta A, Tanaka Y

Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein

cholesterolemia

J Int Med Res 42: 457-467, 2014

Pheochromocytoma Study Group in Japan, Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T,

Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

Endocr Relat Cancer 21: 405-414, 2014

Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T,

Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T,

Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, MInagawa F,

Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y,

Matsuba I

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K

study

Diabetes Res Clin Pract 103: e30-3, 2014

Ohta A , Kato H, Murayama K, Hashimoto E, Murakami M, Nishine A, Ohshige T, Sada Y, Asai S, Kawata T,

Nagai Y, Katabami T, Tanaka Y

Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2

diabetic patients using oral antidiabetic drugs

Endocr J 61: 13-18, 2014

Nagai Y, Hashimoto E, Oikawa R, Asai S, Terashima Y, Nakamura Y, Sasaki Y, Tsukiyama H, Fukuda H,

Ohshige T, Kato H, Ohta A, Tanaka Y

Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes

Diabetes Obes Metab 16: 573-576, 2014

Kawata T, Kanamori A, Kubota A, Maeda H, Amemiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K,

Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y,

Suzuki D, Terauchi Y, Toyoda M, Tanaka Y, Matsuba I

Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?

J Clin Med Res 6: 138-144, 2014

Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, Sasano H, Takeda Y, Shibata H, Sone M, Sato F,

Yamada M, Ueshiba H, Katabami T, Iwasaki Y, Tanaka H, Tanahashi Y, Suzuki S, Hasegawa T, Katsumata N,

Tajima T, Yanase T

Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study

Endocr J 61: 35-40, 2014

■2013年 Ohta A, Arai K, Nishine A, Sada Y, Kato H, Fukuda H, Asai S, Nagai Y, Katabami T, Tanaka Y

Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic

receiving preprandial insulin aspart or postprandial insulin glulisine

Endocr J 60: 173-177, 2013

Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, Tagami T, Okuno H, Yamamoto T, Shimatsu A,

Katabami T, Okumura A, Kawa G, Tanabe A, Naruse M

Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry

J Clin Endocrinol Metab 98: 1567-1574, 2013

Ohta A, Kato H, Nakamura Y, Tenjin A, Sakai K, Tukiyama H, Terashima Y, Nagai Y, Tanaka Y

Cold-loaded pain sensation test and current perception threshold for evaluation of diabetic

neuropathy Diabetol Int 4: 34-39, 2013

Nagai Y, Ohshige T, Arai K, Kobayashi H, Sada Y, Omori S, Furukawa K, Kato H, Kawata T, Ohta A, Tanaka

Y

Comparison between shorter straight and thinner microtapered insulin Injection needles

Diabetes Technol Ther 15: 550-555, 2013

Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A,

Kawamori R, Maeda S

Replication study for the association of a single-nucleotide polymorphism, rs3746876,within

KCNJ15, with susceptibility to type 2 diabetes in a Japanese population

J Human Genet 58: 490-493, 2013

Ohta A, Ohshige T, Sakai K, Nakamura Y, Tenjin A, Tsukiyama S, Terashima Y, Matsubara F, Kawata T,

Nagai Y, Tanaka Y

Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and

voglibose in drug-naïve Japanese patients with type 2 diabetes

Expert Opin Pharmacother 14: 2315-2322, 2013

Erion MD, Popov V, Hsiao JJ, Vatner D, Mitchell K, Yonemitsu S, Nagai Y, Kahn M, Gillum PM, Dong J,

Murray FS, Manchem PV, Bhanot S, Cline WG, Shulman IG, Samuel T

The role of the carbohydrate response element-binding protein in male fructose-fed rats

Endocrinology 154: 36-44, 2013

Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A, Kadowaki

T, Kawamori R, Maeda S

Replication study for association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to

type 2 diabetes in a Japanese population

J Diabetes Invest 4: 168-173, 2013

Kawata T, Ohta A, Nemoto T, Nishisako H, Yamasaki Y, Hirose M, Kunishima H, Matsuda T, Tanaka Y

A Case of Slowly Progressive Insulin-dependent Diabetes Mellitus (SPIDDM) with Low Anti-GAD

Antibody Titer Detected during Treatment of Organizing Pneumonia

General Med 14: 1-5, 2013

Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, ASSET-K Study Group

Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1)

to a target of HbA1c ＜7％

J Endocrinol Invest 36: 568-573, 2013

■2012年 Kubota A, Maeda H, Kanamori A, Matoba K, Jin Y, Minagawa F, Obana M, lemitsu K, Ito S, Amemiya H,

Kaneshiro M, Takai Masahiko, Kanesige H, Hoshino K, Ishikawa M, Minami N, Takuma T, Sasai N,

Aoyagi S, Kawata T, Mokubo A, Takeda H, Honda S, Machimura H, Motomiya T, Waseda M, Naka Y, Tanaka

Y, Terauchi Y, Matsuba I

Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients

J Clin Med Res 4: 309-313, 2012

Maeda H, Kubota A, Tanaka Y, Terauchi Y, Matsuba I, ASSET-K Study Group

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese

type 2 diabetes


Kato H, Ohta A, Kobayashi S, Ishii S, Sada Y, Kobayashi H, Omori S, Kondo A, Katabami T, Fuse J, Fukuda

H, Nagai Y, Tanaka Y

Effect of the α-glucosidase inhibitor miglitol on the glucose profile in Japanese type 2 diabetic

patients receiving multiple daily insulin injections

Endocr J 59: 345-352, 2012

Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M,

Uruno T, Horiuchi K, Miyauchi A, Imamura M; MEN Consortium of Japan, Fukushima T, Hanazaki K,

Hirakawa S, Igarashi T, Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S,

Midorikawa S, Miyabe R, Munekage T, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M

Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database

Clin Endocrinology 76: 533-539, 2012

Miyauchi K, Yamazaki T, Watada H, Tanaka Y, Kawamori R, Imai Y, Ikeda S, Kitagawa A, Ono Y, Murayama

F, Choi BJ, Suwa S, Hayashi D, Kishimoto J, Daida H; for the ADVANCED-J investigators

Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker

in type 2 diabetes

Circulation J 76: 2159-2166, 2012

Imamura M, Maeda S, Yamauchi T, Hara K, Yasuda K, Morizono T, Takahashi A, Horikoshi M, Nakamura M,

Fujita H, Tsunoda T, Kubo M, Watada H, Maegawa H, Okada IM, Iwabu M, Shojima N, Ohshige T, Omori S,

Iwata M, Hirose H, Kaku K, Ito C, Tanaka Y, Tobe K, Kashiwagi A, Kawamori R, Kasuga M, Kamatani N;

Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, Nakamura Y, Kadowaki T

A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in

Japanese populations

Human Molecular Genet 121: 3042-3049, 2012

Kondo A, Ohta A, Kato H, Matsubara F, Fukuda H, Kobayashi H, Kawata T, Tanaka Y

Effect of combination therapy with losartan and low-dose hydrochlorothiazide for albuminuria on the

patients with type 2 diabetes mellitus

Japanese J Clin Physiol 42: 89-95, 2012

Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A,

Kawamori R, Maeda S

A Single nucleotide polymorphism within DUSP9 Is associated with susceptibility to type 2 diabetes

in a Japanese population

PLoS One 7: e46263, 2012

Kawata T, Kanamori A, Kubota A, Maeda H, Matoba K, Ito S, Amamiya H, Takai M, Kaneshige H, Minami N,

Minagawa F, Iemitsu K, Ishikawa M, Hoshino K, Miyakawa M, Naka Y, Toyoda M, Terauchi Y, Suzuki D,

Tanaka Y, Matsuba I

Efficacy and safety of liraglutide in patients with type2 diabetes:the SEDIK study

J Diabetes Invest 3: 203, 2012

Sato T, Katabami T, Furukawa K, Narimatsu H, Hashimoto T, Nakajima Y, Ohta A, Sasaoka T, Tanaka Y

Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone

deficiency without diabetes mellitus

Obesity Res Clin Pract 6: e321-e329, 2012

■2011年 Kamijo IA, Sugaya T, Yasuda T, Kawata T, Ohta A, Tatsunami S, Kaise R, Ishimitsu T, Tanaka Y, Kimura K

Clinical significance of urinary liver-type fatty acid- binding protein in diabetic nephropathy of type 2

diabetic patients

Diabetes Care 34: 691-696, 2011

Sada Y, Katabami T, Asai S, Sato T, Furukawa K, Ishii S, Kato H, Kobayashi H, Kondo A, Ohta A, Nakajima Y,

Tanaka Y

Intrahepatic lipid content is linked to insulin resistance in obese subjects


Ohshige T, Iwata M, Omori S, Tanaka Y, Hirose H, Kaku K, Maegawa H, Watada H, Kashiwagi A, Kawamori

R, Tobe K, Kadowaki T, Nakamura Y, Maeda S

Association of new loci Identified in European genome-wide association studies with susceptibility

to type 2 diabetes in the Japanese

PLoS One 6: e26911, 2011

Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A, Kawamori

R, Nakamura Y, Maeda S

Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2

diabetes in the Japanese population

Diabetologia 54: 3071-3077, 2011

Ohta A, Suwa T, Sada Y, Kato H, Koganei R, Asai S, Katabami T, Tanaka Y

Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic

patients receiving biphasic insulin aspart 30 or biphasic human insulin 30

J Diabetes Invest 2: 406-411, 2011

■2010年 Ohshige T, Tanaka Y, Araki S, Babazono T, Toyoda M, Umezono T, Watada H, Suzuki D, Iwamoto Y,

Kawamori R, Nakamura Y, Maeda S

A single nucleotide polymorphism in KCNQ1 Is associated with susceptibility to diabetic

nephropathy in Japanese subjects with type 2 diabetes

Diabetes Care 33: 842-846, 2010

Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, Sada Y, Ishii S, Kondo A, Murakami K, Katabami T,

Tanaka Y

Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous

glucose monitoring (CGM)

Endocr J 57: 135-140, 2010

Katabami T, Kato H, Asahina T, Hinohara S, Shin T, Kawata T, Ohta A, Iwamoto T, Tanaka Y

Serum free testosterone and metabolic syndrome in Japanese men

Endocr J 57: 533-539, 2010

Furukawa K, Katabami T, Nakajima Y, Sato T, Kato H, Koganai R, Asai S, Matsui T, Sada Y, Kawata T,

Kondo A, Ohta A, Tanaka Y

Evaluation of whole-abdominal fat volume by 700-slice CT scanning and comparison with the

umbilical fat area anthropometric indices


Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi,M Nakamura M, Fujita H, Grarup N,

Cauchi S, Daniel PKN, Ronald CWM, Tsunoda T, Kudo M, Watada H, Maegawa H, Okada IM, Iwabu M,

Shojima N, Shin DH, Andersen G, Witte RD, Jorgensen T, Lauritzen T, Sandbaek A, Hansen T, Ohshige T,

Omori S, Saito I, Kaku K, Hirose H, So WY, Beury D, Chan CNJ, Park SK, Tail SE, Ito C, Tanaka Y,

Kashiwagi A, Kawamori R, Kasuga M, Froguel P, Pedersen O, Kamatani N, Nakamura Y, Kadowaki T

A genome wide association study in the Japanese population identifies susceptibility loci for type 2

diabetes at UBE2E2 and C2CD4A-C2CD4B

Nature Genet 42: 864-868, 2010

■2009年 Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, Yoshihara T, Fujitani Y, Hirose T, Tanaka

Y, Kawamori R

Aldose reductase Inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes

Endocr J 56: 149-156, 2009

Asai S, Katabami T, Obi N, Matsui T, Kato H, Obi R, Ogawa Y, Kawata T, Takama H, Ohta A, Tanaka Y

No ghrelin response to oral glucose in diabetes mellitus with gastroparesis

Endocr J 56: 79-87, 2009

Obi N, Katabami T, Obi R, Odanaka M, Sasano K, Tanaka Y

Primary malignant hepatic glucagonoma : an autopsy case

Endocr J 56: 715-719, 2009

Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T, Kawamori

R

Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with

type 2 diabetes ADVANCED-J study 1

Hypertension Res 32: 770-774, 2009

Omori S, Tanaka Y, Horikoshi M, Takahashi A, Hara K, Hirose H, Kashiwagi A, Kaku K, Kawamori R,

Kadowaki T, Nakamura Y, Maeda S

Replication study for the association of new meta-analysis-derived risk loci with susceptibility to

type 2 diabetes in 6,244 Japanese individuals

Diabetologia 52: 1554-1560, 2009

■2008年 Tamura Y, Watada H, Igarashi Y, Nomiyama T, Onishi T, Takahashi K, Doi S, Katamoto S, Hirose T, Tanaka Y,

Kawamori R

Short-term effects of dietary fat on intramyocellular lipid in sprinters and endurance runners.

Metabolism 57: 373-379, 2008

Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R

Effects of metformin on peripheral Insulin sensitivity and intracellular lipid contents in muscle and

liver of overweight Japanese subjects

Diabetes Obesity Metab 10: 733-738, 2008

Obi N, Katabami T, Asai S, Saito N, Tanaka Y

Fulminant Type 1 diabetes complicated by leukemoid reaction

Intern Med 47: 847-851, 2008

Amano T, Imano T, Takemae K, Iwamoto T, Yamanaka K, Baba K, Nakanome M, Sugimori H, Tanaka Y,

Yoshida K, Katabami T, Tanaka M

Profile of serum testosterone levels after application of testosterone ointment (glowmin) and Its

clinical efficacy in late-onset hypogonadism patients

J Sex Med 5: 1727-1736, 2008

■2007年 Tamura Y, Ogihara T, Uchida T, Ikeda F, Kumashiro N, Nomiyama T, Sato F, Hirose T, Tanaka Y, Mochizuki H,

Kawamori R, Watada H

Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappab in db/db mice

Diabetologia 50: 131-141, 2007

Sugai M, Ohta A, Ogata Y, Nakanishi M, Ueno S, Kawata T, Saito N, Tanaka Y

Asymmetric dimethylarginine(ADMA) in the anqueous humor of diabetic patients

Endocr J 54: 303-309, 2007

Nakaniwa T, Nomiyama T, Takahashi S, Sakai K, Uchino H, Shimizu T, Kanazawa A, Watada H, Hirose T,

Kawamori R, Tanaka Y

Manganese superoxide dismutase polymorphism (V16A) associated with inpaired cardiac

autonomic function in Japanese type 2 deiabetid patients.

Jpn J Clin Physiol 37: 27-34, 2007

Ohta A, Omori S, Obi R, Tanaka Y

Penile necrosis by calciphylaxis in a diabetic patient with chronic renal failure

Internal Med 46: 985-990, 2007

Kumashiro N, Yoshihara T, Kanazawa Y, Shimizu T, Watada H, Tanaka Y, Fujitani Y, Kawamori R, Hirose T

Long-term effect of combination therapy with mitiglinide and once daily Insulin glargine in patients

who were succesfully switched from Intensive Insulin therapy in short-term study

Endocr J 54: 163-166, 2007

Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H, Maehara T, Kyogoku S, Sunayama S, Sato

H, Hirose T, Tanaka Y, Kawamori R

Effects of diet-induced moderate weight reduction on intrahepatic and Intramyocellular triglycerides

and glucose metabolism in obese subjects

J Clin Endocrinology Metab 92: 3326-3329, 2007

Ikeda F, Azuma K, Ogihara T, Toyofuku Y, Otsuka A, Mita T, Hirose T, Tanaka Y, Kawamori R, Watada H

Angiotenshin Ⅱtype 1 receptor blocker reduces monocyte adhesion to endothelial cells in

pontaneously hypertensive rats

Endocr J 54: 605-612, 2007

Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S

Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8 and KCNJ11 with susceptibility to

type 2 diabetes in a Japanese population

Diabetes 57: 791-795, 2007

Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R,

Hirose T

Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of

basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2

diabetes (JUN-LAN Study 1).

Endocr J 54: 975-983, 2007

Mita T, Watada H, Shimizu T, Tamura Y, Sato F, Watanabe T, Choi BJ, Hirose T, Tanaka Y, Kawamori R

Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic

control

Arterioscler Thromb Vasc Biol 27: 2456-2462, 2007

英語論文 - St. Marianna University School of Medicine · Effect of cosyntropin during adrenal...

Documents

Transcript of 英語論文 - St. Marianna University School of Medicine · Effect of cosyntropin during adrenal...